Abstract:The extracellular stability versus intracellular drug release and the long blood stream circulation versus enhanced cell uptake are two dilemmas for micellar drug delivery systems. To resolve the above two problems, a novel core cross-linked polyurethane micelles with redox sensitive and pH-responsive surface charge switchable properties were prepared and investigated as anti-cancer drug carriers. Firstly, amphiphilic multi-blocked polyurethane with pendant carboxyl groups and disulfides in the hard segment (PU-SS-COOH) was synthesized. Afterwards, 1,6-diaminohexane was connected onto some of the pendant carboxyl groups via dicyclohexylcarbodiimide (DCC) condensation, which resulted in polyurethane with pendant amine and carboxyl groups (PU-SS-COOH-NH2). Then the PU-SS-COOH-NH2 was assembled into micelles and the hexamethylene-1,6-diisocyanate (HDI) was added into the micelle solution. The hydrophobic diisocyanate penetrated into the hydrophobic core of PU micelles and reacted with amine groups, which resulted in core crosslinked PU micelles (PU-CCL). PTX and doxorubicin hydrochloride (DOX) were chosen as model hydrophobic drugs to evaluate the loading and redox-triggered release of the PU micelles. The drug release from the cross-linked polyurethane micelles (PU-CCL) demonstrated that the PU-CCL has superior particle stability compared with the uncross-linked polyurethane micelles in a phosphate buffer saline (PBS) solution without reducing agents, whereas the drug release rate is markedly accelerated with the addition of a reducing agent, glutathione (GSH). Notably, PU micelles with both amine and carboxyl groups, i.e. PU-SS-COOH-NH2 and PU-CCL micelles, showed pH-responsive charge switchable properties. The in vitro cytotoxicity and cell uptake of the PTX (or DOX used to illustrate the cell uptake) loaded micelles was also assessed in HepG2 cells. It was found that the redox-sensitive polyurethane micelles can rapidly enter tumor cells. In vitro cytotoxicity studies demonstrated that the DOX-loaded PU-CCL display lower cytotoxicity in vitro compared to either free DOX or DOX-loaded uncrosslinked PU micelles. The cross-linked reduction responsive biodegradable micelles, having superior extracellular stability and providing rapid intracellular drug release, may hold great potential as a bio- triggered drug delivery system for cancer therapy.

Enhanced bioreduction-responsive biodegradable diselenide-containing poly(ester urethane) nanocarriers

Biodegradable Polyurethane Micelles with Ph and Reduction Responsive Properties for Intracellular Drug Delivery.

Biodegradable multi-blocked polyurethane micelles for intracellular drug delivery: the effect of disulfide location on the drug release profile

Biodegradable multiblock polyurethane micelles with tunable reduction-sensitivity for on-demand intracellular drug delivery

GSH-responsive polymeric micelles based on the thio–ene reaction for controlled drug release

Well-defined Labile Diselenide-Centered Poly(ε-Caprolactone)-based Micelles for Activated Intracellular Drug Release.

Surface charge switchable and core cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy

Visible-Light-Induced Diselenide-Crosslinked Polymeric Micelles for ROS-Triggered Drug Delivery

Environment-stimulated nanocarriers enabling multi-active sites for high drug encapsulation as an “on demand” drug release system

Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation

Ph/gsh-Responsive Diselenide-Containing Micelle Via Backbone Ketoxime Cross-Links for Efficient Drug Delivery and Controlled Release

Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro

Sheddable micelles based on disulfide-linked hybrid PEG-polypeptide copolymer for intracellular drug delivery

Dual-stimuli-sensitive poly(ortho ester disulfide urethanes)-based nanospheres with rapid intracellular drug release for enhanced chemotherapy

A Dual-Responsive Polyurethane Nanocarrier for Drug Release Triggered by Intracellular GSH and NQO1 Enzyme

Redox-responsive Polyanhydride Micelles for Cancer Therapy.

Highly Stable RGD/disulfide Bridge-Bearing Star-Shaped Biodegradable Nanocarriers for Enhancing Drug-Loading Efficiency, Rapid Cellular Uptake, and On-Demand Cargo Release

Self-Assembled Micelles Of Peg-Poly(Disulfide Carbamate Amine) Copolymers For Intracellular Dual-Responsive Drug Delivery

Bioreducible Unimolecular Micelles Based on Amphiphilic Multiarm Hyperbranched Copolymers for Triggered Drug Release

Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell

Enhanced Bioreduction-Responsive Diselenide-Based Dimeric Prodrug Nanoparticles for Triple Negative Breast Cancer Therapy.